LDS/Medical Tests/Pneumocystis Smear

Pneumocystis Smear

Pneumocystis jiroveci, previously named Pneumocystis carinii, is a yeast-like fungus present in the respiratory tract of humans as commensals. It can lead to life-threatening opportunistic infection in immunocompromised individuals. Its existence was first noted during the Second World War when premature and severely malnourished infants suffered from interstitial pneumonia.

Almost 75% of children under 5 years of age develop antibodies against P. jiroveci. Under normal circumstances, the organism is incapable of generating significant infection in immunocompetent hosts. In immunocompromised individuals, like those with HIV/AIDS, P. jiroveci may become a highly destructive pathogen, causing Pneumocystis pneumonia (PCP). Around 30-40% of PCP patients are infected with HIV, however, individuals with organ transplantation and those taking immunosuppressant drugs, including corticosteroids) are also vulnerable to developing P. jiroveci infection.

The pathogen is transmitted through the air-borne route and direct droplet inhalation. The symptoms start with fever, chills, cough, chest pain, fatigue, rapidly progressing to difficulty breathing, and pneumonia. P. jiroveci cannot be cultured artificially and its presence should be highly suspected in cases of pneumonia with sterile respiratory cultures, especially in those with compromised immunity. HIV patients can be protected from the infection by appropriate anti-retroviral therapy and anti-pneumocystis prophylaxis. Trimethoprim-sulfamethoxazole is the choice of drug for treating Pneumocystis infection.

P. jiroveci can be detected microscopically by staining broncho-alveolar lavage (BAL) specimens with appropriate dye based (e.g. Gomori’s methanamine silver) or immunofluorescent stains, however, their sensitivity depends upon the observer. DNA amplification by PCR increases the sensitivity by 50% and is considered the gold standard for the diagnosis of P. jiroveci.

  • Aid in diagnosis of P. jiroveci infection
  • Differential diagnosis of pneumonia in immunocompromised patients

A positive result confirms the presence of Pneumocystis jiroveci in the specimen.

A negative result indicates the absence of Pneumocystis jiroveci in the specimen.

Negative (Not seen)

Specific stain, microscopy.

Bronchoalveolar lavage (BAL), bronchial washings (preferred), sputum (induced preferred), tracheal secretion, pleural fluid/effusion.

Stability

  • Ambient: 48 hrs.
  • Refrigerated: 7 days
  • Frozen: 1 month
Direct immunofluorescence by fluorescein-conjugated monoclonal anti-pneumocystis antibody, Gomori’s methanamine, silver stain sputum/BAL culture, fungal culture, CBC, ESR, CRP, Respiratory Pathogen Panel by Molecular method.
1-3 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login